AggRegated System Of sensOrs and Multimedia Monitors: Technology for innovAtion and personalizaTion of rEhabilitation Care. (ROOMMATE)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFrancesca Cecchi

About this trial

The aim of this clinical trial is to assess whether the ROOMMATE system can effectively support the rehabilitation of adults recovering from subacute strokes. The study will be conducted at the neuromotor rehabilitation inpatient clinics of IRCCS Fondazione Don Carlo Gnocchi in Florence, Italy, and the rehabilitation inpatient unit of Elias University Emergency Hospital in Bucharest, Romania.

Primary Objectives:

-To assess the effects on functional recovery in subacute stroke survivors of a technological rehabilitation station placed at patients' bedsides, combined with dedicated coaching provided to all users (patients, informal caregivers, and formal caregivers).

Secondary Objectives:

* Evaluation of the effects of the experimental treatment on patient satisfaction, upper limb motor skills, manual dexterity, global cognitive functioning, anxiety, and depression. * Assessment of user experience, acceptance, and usability of the technology by patients and caregivers. * Evaluation of social impact using the Social Return on Investment (SROI) ratio of the experimental treatment.

Participants randomized into one of the experimental groups, in addition to receiving conventional care, will use the ROOMMATE system during their hospitalization. The system will be made available to patients and will be free for them to use at their discretion.

The station will include:

Multimedia monitors (Khymeia home kit): These will deliver cognitive and motor serious games, educational and rehabilitative content, as well as infotainment specifically developed by the clinical partners of the project.

An inertial sensor kit: This integrates with the monitors to guide users through virtual reality environments.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

outcome of ischemic or hemorrhagic stroke in subacute phase (< 3 months after the event)

willingness to participate in the project, with informed consent signed by the subject or, when necessary, by the support administrator.

Disqualifiers

severe visual and/or auditory impairments that cannot be corrected

severe cognitive and/or speech impairments that interfere with the ability to use the HKK system and the SensoMode accessory independently and/or in the

absence of a caregiver who can assist the patient in using the system;

skin lesions that prevent wearing the inertial sensors;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Active Comparator: Conventional rehabilitation (Group A)

    Other intervention

    The conventional group will undergo standard rehabilitation treatment according to the rehabilitation plan developed by the rehabilitation team. This group will undergo 3 hours of rehabilitation per day and will carry out face-to-face rehabilitation following an impairment-based approach aimed at the treatment of motor-cognitive functions.

  • ROOMMATE 1st

    Device

    In addition to Group A, this group will have the bedside multimedia monitor apparatus to access informative, rehabilitation, and entertainment content. Additionally, this group will have a digital and innovation coach to receive support in using the technology.

  • ROOMMATE 2nd

    Device

    Once the first RCT of the cmRCT is completed, a pilot RCT will be initiated, randomizing 60 cases between Group A and this group. In addition to conventional treatment, this group will have a version of the ROOMMATE system integrated with inertial sensors worn on the hands and fingers to guide the serious games on the platform.

Treatment groups

200 Participants
are divided into 3 treatment groups
Group A: Conventional rehabilitation (Group A)Active comparator 1 intervention
Group B: ROOMMATE 1st (Group B)Experimental treatment 1 intervention
Group C: ROOMMATE 2nd (Goup B2)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

modified Barthel index (mBI)

Assessment of disability in ADLs, scoring 0-100

Time frame
baseline, 3 week

Secondary outcomes

1

Nine Hole Peg Test

Manual Dexterity, evaluated in seconds

Time frame
baseline, 3 week
2

Fugl Meyer Assessment (FMA)

Upper limb motor skills, scoring 0 - 126

Time frame
baseline, 3 week
3

Functional Ambulation Category (FAC)

functional ambulation assessment, scoring 0-5

Time frame
baseline, 3 week
4

Montreal Cognitive Assessment (MOCA)

Cognitive impairment assessment, scoring 0 - 30

Time frame
baseline, 3 week

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Francesca Cecchi

Lead sponsor

Fondazione Don Carlo Gnocchi Onlus

Sponsor institution

MEDEA, Italy

Collaborator

Carol Davila University of Medicine and Pharmacy

Collaborator

Roessingh Research and Development

Collaborator

University of Florence

Collaborator

This trial is not recruiting at the moment. You can still explore other options: